Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Controling Intestinal Colonization of High Risk Patients With Extended Spectrum ß-Lactamase Producing Enterobacteriaceae (ESBL-E) - A Randomized Trial (CLEAR)

NCT01931592 is registered in ClinicalTrials.gov with Maria J.G.T. Vehreschild as lead sponsor.

NCT NCT01931592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01931592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Controling Intestinal Colonization of High Risk Patients With Extended Spectrum ß-Lactamase Producing Enterobacteriaceae (ESBL-E) - A Randomized Trial (CLEAR)
Lead sponsor
Maria J.G.T. Vehreschild
Phase
Phase 2/3
Overall status
Terminated
Start date
January 31, 2014
Completion date
December 31, 2016
Enrollment
29 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer